Catalyzes the reversible transfer of phosphatidyl groups between phosphatidylglycerol molecules, resulting in the formation of cardiolipin (CL, diphosphatidylglycerol) and glycerol.
KEGG: sea:SeAg_B1406
Cardiolipin synthase (cls) in Salmonella agona is an enzyme that catalyzes the synthesis of cardiolipin, a specialized phospholipid crucial for bacterial membrane structure and function. Cardiolipins are involved in the structural organization of membranes, enzyme functioning, and osmoregulation . In Salmonella agona, the cls enzyme (UniProt ID: B5F4L0) is encoded by the cls gene (locus name: SeAg_B1406) and functions as a transesterification enzyme that combines two phospholipid molecules to form cardiolipin .
The enzyme contains characteristic phospholipase D motifs and typically catalyzes the condensation of two phosphatidylglycerol molecules to form cardiolipin and glycerol. This reaction is critical for maintaining proper membrane fluidity, permeability, and stability under various environmental stresses that Salmonella encounters during infection cycles.
The differences between bacterial and archaeal cardiolipin synthases reflect the fundamental differences in membrane lipid composition between these domains of life:
| Feature | Bacterial Cls (e.g., Salmonella) | Archaeal Cls (e.g., M. hungatei) |
|---|---|---|
| Lipid substrate | Fatty acyl chain-based ester phospholipids | Isoprenoid-based ether phospholipids |
| Product | Glycerol-di-phosphatidyl-cardiolipin (Gro-DPCL) | Glycerol-di-archaetidyl-cardiolipin (Gro-DACL) |
| Substrate selectivity | Often more specific | Often promiscuous (can use both bacterial and archaeal lipids) |
| Membrane topology | Two main transmembrane segments | Similar topology with domain-specific variations |
| Evolutionary conservation | Forms distinct phylogenetic clusters | Forms separate evolutionary branches |
For successful expression of functional Recombinant Salmonella agona Cardiolipin synthase:
E. coli expression system: The most commonly used host for expressing bacterial membrane proteins. For cls expression:
Membrane protein expression considerations:
Protein recovery and purification:
Standard methods for assessing Cardiolipin synthase activity include:
LC-MS analysis: The gold standard for quantifying enzyme activity by measuring substrate consumption and product formation
Thin Layer Chromatography (TLC):
Simple method for separating and visualizing lipid products
Can be quantified by densitometric analysis of stained spots
Useful for rapid screening of enzyme activity
Fluorescent substrate assays:
Employ fluorescently labeled phospholipid substrates
Allow real-time monitoring of enzyme kinetics
Enable high-throughput screening of enzyme variants or inhibitors
Activity verification approach:
Investigating substrate specificity of Salmonella agona Cardiolipin synthase requires a systematic approach:
Substrate panel testing: Evaluate enzyme activity with structurally diverse phospholipids:
Competition assays:
Provide the enzyme with an equimolar mixture of different substrates
Identify preferential utilization through LC-MS analysis of substrate consumption rates
For example, mixing "palmitoyl-oleoyl phosphatidylglycerol (POPG 16:0/18:1) and di-oleoyl-di-oleoyl-glycerol-di-phosphatidyl-cardiolipin (Gro-DPCL 18:1/18:1/18:1/18:1)" to detect formation of hybrid products
Kinetic parameter determination:
Measure initial reaction rates at varying substrate concentrations
Calculate Km, Vmax, and catalytic efficiency (kcat/Km) for each substrate
Create Michaelis-Menten plots to visualize enzyme kinetics
Structural basis of specificity:
Perform site-directed mutagenesis of putative substrate-binding residues
Analyze how mutations affect substrate preference using activity assays
Use homology modeling and molecular docking to predict substrate interactions
Studying the role of Cardiolipin synthase in Salmonella pathogenesis involves multiple complementary approaches:
Genetic manipulation strategies:
Generate cls gene knockouts in Salmonella agona using CRISPR-Cas9 or allelic exchange methods
Create point mutations in catalytic residues to produce enzymatically inactive variants
Develop conditional knockout systems for temporal control of cls expression
Infection models:
Stress response analysis:
Challenge wild-type and cls-deficient strains with various stressors relevant to infection:
Acid stress (stomach-like conditions)
Osmotic stress (intestinal environment)
Oxidative stress (macrophage phagosome)
Antimicrobial peptides (host defense molecules)
Membrane biology assessments:
Analyze membrane fluidity changes using fluorescence anisotropy
Measure membrane potential and permeability
Quantify resistance to membrane-targeting antimicrobials
Examine localization of virulence-associated membrane proteins
Transmission electron microscopy:
Visualize membrane ultrastructure in cls mutants compared to wild-type
Assess membrane defects during different growth phases
Examine septum formation during cell division
Developing Cardiolipin synthase inhibitors requires several methodological considerations:
Target validation approaches:
Determine essentiality of cls in Salmonella under various growth conditions
Analyze phenotypic consequences of cls inhibition
Establish cls as a druggable target through structural and functional studies
High-throughput screening frameworks:
Develop cell-based assays to monitor cardiolipin levels
Design in vitro enzymatic assays amenable to HTS format
Establish counter-screening methods to exclude non-specific membrane disruptors
Structure-based design considerations:
Identify druggable pockets in the enzyme structure
Target catalytic residues or substrate binding sites
Design transition state analogs that mimic the phosphodiester bond formation
Selectivity assessment:
Compare inhibitor effects on bacterial vs. mitochondrial cardiolipin synthases
Evaluate activity against other phospholipase D-like enzymes
Test effects on commensal microbiota
Delivery strategies for membrane enzyme inhibitors:
Develop lipophilic prodrugs to enhance membrane penetration
Consider nanoparticle-based delivery systems
Optimize physicochemical properties for bacterial membrane permeability
Investigating Cardiolipin synthase interactions with other membrane components requires specialized techniques:
Membrane protein interactome analysis:
Affinity purification coupled with mass spectrometry (AP-MS)
Bacterial two-hybrid systems adapted for membrane proteins
Proximity-dependent biotin labeling (BioID) to identify neighboring proteins
Dynamic interaction studies:
Fluorescence resonance energy transfer (FRET) with fluorescently tagged proteins
Bimolecular fluorescence complementation (BiFC)
Single-molecule tracking in live cells
Lipid raft and membrane microdomain analysis:
Detergent-resistant membrane isolation
Super-resolution microscopy to visualize protein clustering
Correlative light and electron microscopy (CLEM)
Functional complex reconstitution:
Co-expression of cls with putative interaction partners
Reconstitution into liposomes or nanodiscs
Activity assays in the presence/absence of interaction candidates
Computational approaches:
Molecular dynamics simulations of cls in membrane environments
Protein-protein docking predictions
Network analysis of membrane protein interactions
To study environmental influences on Cardiolipin synthase activity:
Temperature-dependent activity profiling:
Measure enzyme kinetics across temperature ranges relevant to host and environmental niches
Determine thermal stability using differential scanning fluorimetry
Analyze temperature-dependent conformational changes via circular dichroism
pH responsiveness studies:
Establish pH-activity profiles using buffered reaction systems
Investigate pH-dependent structural changes
Develop pH-responsive assay systems that mimic phagosomal acidification
Ion and osmolyte effects:
Test activity in the presence of varying concentrations of physiologically relevant ions (Mg²⁺, Ca²⁺)
Examine effects of osmolytes on enzyme stability and activity
Correlate with Salmonella adaptation to osmotic stress environments
Oxygen tension considerations:
Compare enzyme activity under aerobic vs. anaerobic conditions
Develop oxygen-controlled reaction chambers for real-time monitoring
Correlate with Salmonella's lifestyle in different host niches
Nutrient availability impact:
Analyze how carbon source affects cls expression and activity
Investigate phosphate limitation effects on cardiolipin synthesis
Develop chemically defined media to control nutrient variables
Evaluating evolutionary conservation of Cardiolipin synthase involves these approaches:
Phylogenetic analysis methods:
Sequence conservation mapping:
Structural conservation assessment:
Functional complementation studies:
Express cls from diverse species in model organism knockout strains
Test ability to restore cardiolipin synthesis in heterologous hosts
Compare enzymatic parameters across orthologs
Synteny analysis:
Examine conservation of genomic context around the cls gene
Identify co-evolved gene clusters that may function together
Trace evolutionary events such as gene duplications or horizontal transfers
Techniques for quantifying cardiolipin levels in bacterial membranes include:
Liquid Chromatography-Mass Spectrometry (LC-MS):
Thin Layer Chromatography (TLC):
More accessible technique for routine analysis
Separates cardiolipin from other phospholipids based on polarity
Can be coupled with densitometric analysis for semi-quantitative results
Various staining methods available (iodine vapor, phosphomolybdic acid)
Fluorescent probe-based approaches:
Use of cardiolipin-specific dyes like nonyl acridine orange (NAO)
Flow cytometry for population-level analysis
Fluorescence microscopy for visualization of cardiolipin distribution
Enables live-cell monitoring of cardiolipin dynamics
31P Nuclear Magnetic Resonance (NMR) Spectroscopy:
Non-destructive analysis of phospholipid composition
Can distinguish cardiolipin based on unique phosphate signals
Allows analysis of membrane dynamics in various conditions
Enzyme-linked immunosorbent assay (ELISA):
When studying Cardiolipin synthase mutants, researchers should consider:
Mutation design strategy:
Target catalytic residues within conserved HKD motifs
Modify substrate binding regions to alter specificity
Create truncations to determine minimal functional domains
Design chimeric enzymes to investigate domain-specific functions
Expression system considerations:
Use inducible promoters for precise control of expression timing and level
Utilize complementation systems in cls-deficient strains
Consider the impact of expression tags on protein folding and activity
Validate protein expression via Western blotting with tag-specific antibodies
Phenotypic characterization approach:
Growth curve analysis under various stress conditions
Membrane integrity assessment using fluorescent dyes
Cell morphology examination via microscopy
Antibiotic susceptibility testing, especially for membrane-targeting compounds
Biochemical activity assessment:
Compare wild-type and mutant enzyme kinetics
Analyze substrate specificity changes
Determine alterations in product profiles via LC-MS
Measure hydrolytic side reactions (e.g., phospholipase D activity)
Structure-function correlation:
Use circular dichroism to assess secondary structure changes
Employ limited proteolysis to examine conformational differences
Apply computational modeling to predict mutation effects
Consider detergent effects on mutant protein stability
Lipidomic approaches offer powerful tools for understanding Cardiolipin synthase function:
Global lipidomic profiling:
High-resolution mass spectrometry to identify all lipid species
Comparison of wild-type and cls mutant membrane composition
Detection of compensatory changes in other phospholipids when cardiolipin synthesis is altered
Monitoring of precursor accumulation (e.g., phosphatidylglycerol)
Stable isotope labeling:
Incorporate isotopically labeled precursors (e.g., 13C-glycerol)
Track flux through the cardiolipin synthesis pathway
Determine turnover rates of cardiolipin in different growth conditions
Identify alternative synthetic routes when cls is inhibited
Spatial lipidomics:
MALDI imaging mass spectrometry of bacterial colonies
Subcellular fractionation to analyze domain-specific lipid compositions
Visualization of cardiolipin-enriched membrane domains
Correlation with protein localization data
Targeted lipidomic analysis:
Multiple Reaction Monitoring (MRM) for specific cardiolipin species
Quantification of cardiolipin remodeling intermediates
Analysis of acyl chain composition under various stressors
Detection of oxidized cardiolipin species during stress responses
Integration with other -omics data:
Correlate lipidomic changes with transcriptomic alterations
Connect membrane composition to metabolomic profiles
Develop predictive models of lipid metabolism regulation
Identify potential compensatory mechanisms in cls mutants
Promising future research directions include:
Structural biology advances:
Cryo-electron microscopy to determine membrane-embedded cls structure
Time-resolved structural studies to capture catalytic intermediates
Investigation of conformational changes during substrate binding and product release
Structure-guided inhibitor design targeting Salmonella-specific features
Synthetic biology applications:
Engineer cls variants with novel substrate specificities
Develop biosensors for cardiolipin detection in live cells
Create synthetic minimal membranes with defined cardiolipin content
Explore cls as a tool for synthesizing novel phospholipid structures
Host-pathogen interaction studies:
Investigate how host immunity targets bacterial cardiolipin
Examine cardiolipin's role in Salmonella survival within macrophages
Study the impact of cardiolipin on host immune receptor signaling
Develop cardiolipin-based adjuvants for Salmonella vaccines
Systems biology integration:
Create comprehensive models of phospholipid metabolism
Map regulatory networks controlling cls expression
Investigate metabolic dependencies on cardiolipin synthesis
Develop predictive models of membrane adaptation to environmental changes
Translational research avenues:
Explore cls as a target for novel antimicrobials
Investigate cardiolipin-dependent virulence mechanisms
Develop diagnostic tools based on Salmonella-specific cardiolipin profiles
Create cls-based biosensors for Salmonella detection in food safety applications